Key result
Transendocardial injection of expanded autologous CD34+ cells was evaluated as a treatment strategy following myocardial infarction.
Key points are not available for this paper at this time.
International audience
No takes yet. Share an insight, caveat, or question.
Roncalli et al. (2025) studied this question. Transendocardial injection of expanded autologous CD34+ cells was evaluated as a treatment strategy following myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: